DSE/SILCOPHL (DSE/SILCOPHL)

Dhaka Stock Exchange: DSE/SILCOPHL · BDT

BDT 14.8

-0.10 (-0.7%)· Recorded snapshot

Market cap	1.5B
Revenue (ttm)	408.7M
Net income (ttm)	34.2M
EPS (ttm)	BDT 0.33
Shares out	103.8M
P/E (trailing)	44.7x
Dividend	BDT 0.11 (0.74%)
Volume	273,684
Beta	0.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 408.7M
Net income (ttm): 34.2M
EPS (ttm): BDT 0.33
P/E (trailing): 44.7x
Market cap: 1.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E44.7

P25 n/aP50 n/aP75 n/a

ROE1.4

P25 n/aP50 n/aP75 n/a

ROIC1.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/SILCOPHL indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

BDT

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-12-08
Employees	313
Employees change	2
Employees growth	0.64%
Enterprise value	BDT 1.5B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1995
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BD0495SILCO6
Last earnings date	2026-04-29
Last refreshed	2026-10-29
Last stock split date	2019-11-20
Last stock split type	Forward
Market cap	BDT 1.5B
Next earnings date	2026-12-08
Price	BDT 14.80
Price currency	BDT
SIC code	2834
Stock price date	2026-10-29
Symbol	dse/SILCOPHL
Website	https://www.silcopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	33.1x
Average P/E ratio (3Y)	40.36x
Average P/E ratio (5Y)	37.26x
Earnings yield	2.24%
EV/Earnings	44.39x
EV/EBIT	22.68x
EV/EBITDA	9.44x
EV/FCF	88.27x
EV/Sales	3.72x
FCF / EV yield	1.13%
FCF yield	1.11%
Graham number	13.16141
Graham upside	-11.67%
Industry P/E	9.79x
Lynch fair value	BDT 1.65
Lynch upside	-88.9%
P/B ratio	0.64x
P/E ratio	44.73x
P/FCF ratio	89.85x
P/OCF ratio	21.13x
P/S ratio	3.78x
Price / tangible book value	0.64x
Price/EBITDA ratio	9.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.39%
EBITDA margin	38.26%
Effective tax rate	49.04%
FCF margin	4.21%
Gross margin	34.09%
Operating margin	16.39%
Pretax margin	16.43%
Profit margin	8.37%
ROA	1.48%
ROA (5Y)	1.74%
ROCE	2.61%
ROE	1.42%
ROE (5Y)	2.85%
ROIC	1.43%
ROIC (5Y)	2.63%
Tax / revenue	8.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-26.71%
EPS growth (Q)	-61.54%
EPS growth (QoQ)	-54.55%
EPS growth 3Y	-20.65%
EPS growth 5Y	-16.4%
FCF growth (QoQ)	-62.73%
Gross profit growth	4.4%
Gross profit growth (Q)	-34.29%
Gross profit growth 3Y	-0.85%
Gross profit growth 5Y	-7.49%
Net income growth	-26.48%
Net income growth (Q)	-60.23%
Net income growth (QoQ)	-51.92%
Net income growth 3Y	-20.62%
Net income growth 5Y	-16.39%
OCF growth	-16.04%
OCF growth (QoQ)	-30.27%
OCF growth 3Y	-26.91%
OCF growth 5Y	-18.68%
Operating income growth	11.52%
Operating income growth (Q)	-61.04%
Operating income growth 3Y	1.22%
Operating income growth 5Y	-7.85%
Revenue growth	-4.65%
Revenue growth (Q)	-20.51%
Revenue growth (QoQ)	-21.41%
Revenue growth 3Y	-0.78%
Revenue growth 5Y	-9.71%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -56M
Depreciation and amortization	BDT 89.4M
EBIT	BDT 67M
EBITDA	BDT 156.4M
EPS	BDT 0.33
FCF per share	BDT 0.17
Financing cash flow	BDT -13.3M
Free cash flow	BDT 17.2M
Gross profit	BDT 139.3M
Income taxes	BDT 32.9M
Investing cash flow	BDT -56M
Net borrowing	BDT -4.9M
Net cash flow	BDT 3.9M
Net income	BDT 34.2M
Operating income	BDT 67M
Revenue	BDT 408.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.69
Book value per share	BDT 23.27
Debt / EBITDA	0.01
Debt / equity	0
Debt / FCF	0.07
Interest coverage	138.96
Long-term assets	BDT 1.7B
Long-term liabilities	BDT 155.6M
Net cash (debt)	BDT 27.3M
Net cash / market cap	1.77%
Net cash growth	47.07%
Net debt / EBITDA	-0.17
Net debt / equity	-0.01
Net debt / FCF	-1.59
Piotroski F-Score	6
Property, plant and equipment	BDT 1.7B
Shareholders' equity	BDT 2.4B
Tangible book value	BDT 2.4B
Tangible book value per share	BDT 23.27
Total assets	BDT 2.8B
Total cash	BDT 28.6M
Total debt	BDT 1.3M
Total liabilities	BDT 376.2M
WACC	6.04%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.14
Current assets	BDT 1.1B
Current liabilities	BDT 220.6M
Current ratio	4.81
Inventory turnover	0.58
Net working capital	BDT 812M
Quick ratio	2.1
Working capital	BDT 839.3M
Working capital turnover	0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.31%
Dividend growth	-54.55%
Dividend growth (3Y)	-44.97%
Dividend growth (5Y)	-45.07%
Dividend growth years	1
Dividend payment date	2027-02-21
Dividend payment years	8
Dividend payout frequency	Annual
Dividend per share	BDT 0.11
Dividend yield	0.74%
Ex-dividend date	2026-11-26
FCF payout ratio	30.15%
Last dividend	BDT 0.05
Payout ratio	23.68%
Shareholder yield	0.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BDT 17.57
1D price change	-0.67%
1M price change	-12.43%
1M total return	-12.43%
1W price change	-0.67%
1W total return	-0.67%
1Y price change	8.82%
1Y return CAGR	9.72%
1Y total return	9.71%
20-day SMA	BDT 15.14
200-day SMA	BDT 16.66
3M price change	-31.16%
3M total return	-31.16%
3Y price change	-36.75%
3Y return CAGR	-13.38%
3Y total return	-35.02%
50-day SMA	BDT 16.55
50-day SMA vs 200-day SMA	50under200
52-week high	BDT 23.30
52-week high date	2026-07-19
52-week low	BDT 11.10
52-week low date	2025-11-16
5Y price change	-47.7%
5Y return CAGR	-10.6%
5Y total return	-42.9%
6M price change	5.71%
6M total return	5.71%
All-time high	BDT 37.18
All-time high date	2019-11-07
All-time low	BDT 11.10
All-time low date	2025-11-16
Average true range (ATR)	BDT 0.66
Average volume	248.9K
Beta (1Y)	0.13
Beta (2Y)	0.09
Beta (5Y)	0.32
Change from 52-week high	-36.48%
Change from 52-week low	33.33%
Change from all-time high	-60.2%
Change from all-time low	33.33%
Dollar volume	BDT 4.1M
High price	BDT 14.90
Low price	BDT 14.60
Monthly RSI	44.34
Position in 52-week range	66.67%
Previous close	BDT 14.90
Price vs 150-day SMA	-15.77%
Price vs 20-day SMA	-2.21%
Price vs 200-day SMA	-11.19%
Price vs 50-day SMA	-10.56%
Relative volume	1.11
RSI	42.04
Sharpe ratio	-0.03
Sharpe ratio (3Y)	-0.3
Sharpe ratio (5Y)	-0.29
Sortino ratio	0.1
Sortino ratio (3Y)	-0.29
Sortino ratio (5Y)	-0.26
Volume	273.7K
Weekly RSI	0
YTD price change	9.63%
YTD total return	9.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	5.78%
Shares change (YoY)	0.31%
Shares outstanding	103.8M

Deeper analysis on DSE/SILCOPHL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/SILCOPHL report

Is a complete DSE/SILCOPHL research report available?

No complete published report is available for dse/SILCOPHL (DSE/SILCOPHL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/SILCOPHL (DSE/SILCOPHL)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/SILCOPHL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/SILCOPHL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/SILCOPHL

Frequently asked questions